Ballarpur Industries, owned by the Gautam Thapar-run Avantha Group, is one of the largest paper and pulp manufacturers in the country, with an installed capacity of over 1 million tonnes. The company ranks 211 on our list. Production is spread over five factories in Haryana, Maharashtra, Odisha, and Andhra Pradesh. There’s also a factory in Malaysia. Between them, these factories produce 2.6% of the world’s paper. Per capita consumption of paper in India stands at 10 kg, and the industry has been growing at about 8% year on year. For 2013-14, domestic production is estimated to be 11.38 million tonnes. The industry mostly uses wood, bamboo, recycled fibre, wheat straw, and rice husk as raw materials. Ballarpur is one of the few large organised players in an industry otherwise dominated by small and medium players, with installed capacity of some 50,000 tonnes a year.
Top Stories
Enterprise
Paper Tiger
Ballarpur is one of the few large organised players in an industry otherwise dominated by small and medium players, with installed capacity of some 50,000 tonnes a year.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.